chr8-144466970-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001369769.2(KIFC2):c.190C>T(p.Pro64Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,595,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001369769.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIFC2 | NM_001369769.2 | c.190C>T | p.Pro64Ser | missense_variant | 3/18 | ENST00000645548.2 | NP_001356698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIFC2 | ENST00000645548.2 | c.190C>T | p.Pro64Ser | missense_variant | 3/18 | NM_001369769.2 | ENSP00000494595.1 | |||
KIFC2 | ENST00000301332.3 | c.190C>T | p.Pro64Ser | missense_variant | 3/17 | 1 | ENSP00000301332.2 | |||
KIFC2 | ENST00000642354.1 | c.190C>T | p.Pro64Ser | missense_variant | 3/18 | ENSP00000496539.1 | ||||
KIFC2 | ENST00000643461.1 | n.567C>T | non_coding_transcript_exon_variant | 3/17 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152228Hom.: 0 Cov.: 36
GnomAD3 exomes AF: 0.0000325 AC: 7AN: 215546Hom.: 0 AF XY: 0.0000249 AC XY: 3AN XY: 120248
GnomAD4 exome AF: 0.0000104 AC: 15AN: 1442878Hom.: 0 Cov.: 73 AF XY: 0.0000111 AC XY: 8AN XY: 717702
GnomAD4 genome AF: 0.000131 AC: 20AN: 152344Hom.: 0 Cov.: 36 AF XY: 0.000107 AC XY: 8AN XY: 74498
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 24, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at